Blog

Home  /  News   /  The 5th pilot rapid assessment of WP5 JA2 Strand B on “Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation” is now available.

The 5th pilot rapid assessment of WP5 JA2 Strand B on “Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation” is now available.

We are pleased to announce that the 5th pilot rapid assessment of WP5 JA2 Strand B on “Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation” is available.

Mitral regurgitation (MR) is a common heart valve disorder. There are two types of chronic MR: primary (degenerative) MR and secondary (functional) MR. Three different transcatheter mitral valve repair devices and procedures are approved in Europe for the treatment of adult patients with chronic MR: MitraClip® System (Abbott Vascular International) for leaflet repair, CARILLON® Mitral Contour System® (Cardiac Dimensions, Inc.) for annulus repair, and NeoChord DS1000 (NeoChord, Inc.) for chordal repair.

This assessment addresses the research question whether the use of such technologies is more effective and/or safer than their comparators, which were chosen based on CE mark indications, recommendations in clinical guidelines for the treatment of MR and EUnetHTA guidelines.

wp5-sb-15_final_project_plan
wp5-sb-15_transcatheter_implantable_dvices_for_mitral_valve_repair
wp5-sb-15_comments_tables